[1] |
王莉, 江春, 陈春英. 可溶性B7-H4在早期卵巢癌诊断中的价值[J]. 中国现代医学杂志, 2014, 24(23):107-109.
|
[2] |
OKUDELA K, KATAYAMA A, WOO T, et al. Proteome analysis for downstream targets of oncogenic KRAS-the potential participation of CLIC4 in carcinogenesis in the lung[J]. PLoS One, 2014, 9(2):e87193.
|
[3] |
YAO Q, QU X, YANG Q, et al. CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer[J]. Oncol Rep, 2009, 22(3):541-548.
|
[4] |
TAHERIAN-ESFAHANI Z, TAHERI M, DASHTI S, et al. Assessment of the expression pattern of mTOR-associated lncRNAs and their genomic variants in the patients with breast cancer[J]. J Cell Physiol, 2019, 234(12):22044-22056.
DOI
URL
|
[5] |
ZHANG T, CAO C, WU D, et al. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma[J]. Tumour Biol, 2016, 37(2):2379-2385.
DOI
URL
|
[6] |
PRAT J. Ovarian,fallopian tube and peritoneal cancer staging:rationale and explanation of new FIGO staging 2013[J]. Best Pract Res Clin Obstet Gynaecol, 2015, 29(6):858-869.
DOI
URL
|
[7] |
NASIOUDIS D, WILSON E, MASTROYANNIS S A, et al. Prognostic significance of elevated pre-treatment serum CA-125 levels in patients with stage Ⅰ ovarian sex cord-stromal tumors[J]. Eur J Obstet Gynecol Reprod Biol, 2019, 238:86-89.
DOI
URL
|
[8] |
邓森灵, 兰代群, 曹雅文, 等. 血清miR-222、HE4及CA125水平联合ROMA 指数对上皮性卵巢癌的诊断价值[J]. 现代妇产进展, 2021, 30(3):189-192.
|
[9] |
GUO J, YANG W L, PAK D, et al. Osteopontin,macrophage migration inhibitory factor and anti-interleukin-8 autoantibodies complement CA125 for detection of early stage ovarian cancer[J]. Cancers(Basel), 2019, 11(5):596.
|
[10] |
和晓利, 张菊新, 靖爽, 等. 血清人附睾蛋白4和糖链抗原125诊断卵巢癌的价值[J]. 中华实用诊断与治疗杂志, 2017, 31(3):245-247.
|
[11] |
黄斌. HE4联合CA125对早期卵巢癌的诊断价值研究[J]. 实用癌症杂志, 2016, 31(5):720-722.
|
[12] |
王秋兰, 薛永杰, 韩涛. 人胃癌组织中CLIC4基因表达与微卫星不稳定性的关系[J]. 肿瘤防治研究, 2016, 43(7):572-576.
|
[13] |
SINGHA B, HARPER S L, GOLDMAN A R, et al. CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer[J]. Sci Rep, 2018, 8(1):14725.
DOI
URL
|
[14] |
YAO Q, QU X, YANG Q, et al. CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer[J]. Oncol Rep, 2009, 22(3):541-548.
|
[15] |
SONG Y, PAN Y, LIU J. Functional analysis of lncRNAs based on competitive endogenous RNA in tongue squamous cell carcinoma[J]. Peer J, 2019, 7:e6991.
DOI
URL
|
[16] |
ZHANG P F, WANG F, WU J, et al. LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma[J]. J Cell Physiol, 2019, 234(3):2788-2794.
DOI
URL
|
[17] |
罗涛, 彭细娟, 杨彦龙. 长链非编码RNA SNHG3在神经胶质瘤中的表达及临床意义[J]. 解放军医学院学报, 2018, 39(12):1093-1096.
|
[18] |
HONG L, CHEN W, WU D, et al. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer[J]. Cancer Biomark, 2018, 22(3):367-374.
DOI
URL
|